Ocular Surface

Treatment with stem cells may be among the considerations in patients with ocular surface disease who have not responded to traditional therapy, according to a speaker at the Twin Cities Ocular Surface Disease Symposium.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

Bausch + Lomb has announced the U.S. commercial launch of Miebo, a perfluorohexyloctane ophthalmic solution designed to treat signs and symptoms of dry eye disease by directly targeting tear evaporation.

MARCO ISLAND, Fla. — In this Healio Video Perspective, Alice T. Epitropoulos, MD, FACS, shares pearls for the detection and treatment of neurotrophic keratitis she presented at the Women in Ophthalmology Summer Symposium.

Talking about the importance of a healthy ocular surface is part of my routine education for glaucoma patients.

Verséa Ophthalmics will distribute Celularity’s Biovance and Biovance 3L Ocular products for ocular surface disease treatment and ocular surgical support under the terms of an exclusive U.S. commercialization agreement.

Eye care providers consider scleral lenses to be a first-choice treatment for patients with corneal irregularity, although the lenses were not favored for ocular surface disease, according to a study published in Eye & Contact Lenses.

Eye drops for glaucoma are associated with various adverse effects on the ocular surface that often lead to treatment nonadherence and poor outcomes with surgery, according to a report published in Ocular Surface.

Dry eye in thyroid eye disease appeared to primarily manifest as evaporative dry eye disease in a cohort of treatment-naive patients in China, according to study results published in Journal of Clinical Medicine.